{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:30:40Z","timestamp":1786422640224,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0003"],"award-info":[{"award-number":["P3-0003"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0307"],"award-info":[{"award-number":["P3-0307"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J3-7460"],"award-info":[{"award-number":["J3-7460"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Treatment options for recurrent head and neck tumours in the previously irradiated area are limited, including re-irradiation due to radioresistance of the recurrent tumour and previous dose received by surrounding normal tissues. As an in vitro model to study radioresistance mechanisms, isogenic cells with different radiosensitivity can be used. However, they are not readily available. Therefore, our objective was to establish and characterize radioresistant isogenic human pharyngeal squamous carcinoma cells and to evaluate early radiation response in isogenic parental, radioresistant and radiosensitive cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Radioresistant cells were derived from parental FaDu cells by repeated exposure to ionizing radiation. Radiosensitivity of the established isogenic radioresistant FaDu-RR cells was evaluated by clonogenic assay and compared to isogenic parental FaDu and radiosensitive 2A3 cells. Additional phenotypic characterization of these isogenic cells with different radiosensitivity included evaluation of chemosensitivity, cell proliferation, cell cycle, radiation-induced apoptosis, resolution of DNA double-strand breaks, and DNA damage and repair signalling gene expression before and after irradiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the newly established radioresistant cells in response to 5\u2009Gy irradiation, we observed no alteration in cell cycle regulation, but delayed induction and enhanced resolution of DNA double-strand breaks, lower induction of apoptosis, and pronounced over-expression of DNA damage signalling genes in comparison to parental cells. On the other hand, radiosensitive 2A3 cells were arrested in G<jats:sub>2<\/jats:sub>\/M-phase in response to 5\u2009Gy irradiation, had a prominent accumulation of and slower resolution of DNA double-strand breaks, and no change in DNA damage signalling genes expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We concluded that the emergence of the radioresistance in the established radioresistant isogenic cells can be at least partially attributed to the enhanced DNA double-strand break repair, altered expression of DNA damage signalling and repair genes. On the other hand, in radiosensitive isogenic cells the reduced ability to repair a high number of induced DNA double-strand breaks and no transcriptional response in DNA damage signalling genes indicate on a lack of adaptive response to irradiation. Altogether, our results confirmed that these isogenic cells with different radiosensitivity are an appropriate model to study the mechanisms of radioresistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-019-1418-6","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T16:02:56Z","timestamp":1574870576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines"],"prefix":"10.1186","volume":"14","author":[{"given":"Vesna","family":"Todorovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajda","family":"Prevc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Niksic","family":"Zakelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Savarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreja","family":"Brozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaz","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primoz","family":"Strojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Cemazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-5670","authenticated-orcid":false,"given":"Gregor","family":"Sersa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"issue":"2","key":"1418_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coms.2014.01.001","volume":"26","author":"N Vigneswaran","year":"2014","unstructured":"Vigneswaran N, Williams MD. Epidemiologic trends in head and neck Cancer and aids in diagnosis. Oral Maxillofac Surg Clin Nort Am. 2014;26(2):123\u201341.","journal-title":"Oral Maxillofac Surg Clin Nort Am"},{"issue":"3","key":"1418_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386\u201396.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"1418_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00066-014-0605-5","volume":"190","author":"A Arenz","year":"2014","unstructured":"Arenz A, Ziemann F, Mayer C, Wittig A, Dreffke K, Preising S, et al. Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis. Strahlentherapie und Onkol. 2014;190(9):839\u201346.","journal-title":"Strahlentherapie und Onkol"},{"issue":"2","key":"1418_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.radonc.2013.03.013","volume":"107","author":"T Rieckmann","year":"2013","unstructured":"Rieckmann T, Tribius S, Grob TJ, Meyer F, Busch C-JJ, Petersen C, et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol. 2013;107(2):242\u20136.","journal-title":"Radiother Oncol"},{"key":"1418_CR5","doi-asserted-by":"crossref","unstructured":"Prevc A, Kranjc S, Cemazar M, Todorovic V, Zegura B, Novak M, et al. Dose-Modifying Factor of Radiation Therapy with Concurrent Cisplatin Treatment in HPV-Positive Squamous Cell Carcinoma: A Preclinical Study. Radiat Res. 2018;189(6):1-8.","DOI":"10.1667\/RR14984.1"},{"issue":"1","key":"1418_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon JP, le Ma\u00eetre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4\u201314.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1418_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/hed.23542","volume":"37","author":"P Strojan","year":"2015","unstructured":"Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AWM, et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck. 2015;37(1):134\u201350.","journal-title":"Head Neck"},{"issue":"1","key":"1418_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","volume":"100","author":"P Blanchard","year":"2011","unstructured":"Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol. 2011;100(1):33\u201340.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1418_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/09553002.2014.873557","volume":"90","author":"N McDermott","year":"2014","unstructured":"McDermott N, Meunier A, Lynch TH, Hollywood D, Marignol L. Isogenic radiation resistant cell lines: development and validation strategies. Int J Radiat Biol. 2014;90(2):115\u201326.","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"1418_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00795-017-0171-x","volume":"50","author":"Y Kuwahara","year":"2017","unstructured":"Kuwahara Y, Roudkenar MH, Urushihara Y, Saito Y, Tomita K, Roushandeh AM, et al. Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance. Med Mol Morphol. 2017;50(4):195\u2013204.","journal-title":"Med Mol Morphol"},{"issue":"1","key":"1418_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13014-016-0672-0","volume":"11","author":"A Michna","year":"2016","unstructured":"Michna A, Sch\u00f6tz U, Selmansberger M, Zitzelsberger H, Lauber K, Unger K, et al. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks. Radiat Oncol. 2016;11(1):94.","journal-title":"Radiat Oncol"},{"issue":"1","key":"1418_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1758-3284-3-9","volume":"3","author":"M Harris","year":"2011","unstructured":"Harris M, Wang XG, Jiang Z, Goldberg GL, Casadevall A, Dadachova E. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line. Head Neck Oncol. 2011;3(1):9.","journal-title":"Head Neck Oncol"},{"key":"1418_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0091-679X(08)60516-6","volume":"33","author":"F Otto","year":"1990","unstructured":"Otto F. DAPI staining of fixed cells for high-resolution flow cytometry of nuclear DNA. Methods Cell Biol. 1990;33:105\u201310.","journal-title":"Methods Cell Biol"},{"issue":"4","key":"1418_CR14","first-page":"298","volume":"15","author":"A Pogacnik","year":"1993","unstructured":"Pogacnik A, Us-Krasovec M, Bracko M. Preparation of fine needle aspiration biopsy samples for flow cytometric analysis. Anal Quant Cytol Histol. 1993;15(4):298\u2013302.","journal-title":"Anal Quant Cytol Histol"},{"issue":"3","key":"1418_CR15","first-page":"1658","volume":"41","author":"MNMN Zakelj","year":"2019","unstructured":"Zakelj MNMN, Prevc A, Kranjc S, Cemazar M, Todorovic V, Savarin M, et al. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts. Oncol Rep. 2019;41(3):1658\u201368.","journal-title":"Oncol Rep"},{"key":"1418_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2015.07.001","volume":"766","author":"MS Siddiqui","year":"2015","unstructured":"Siddiqui MS, Fran\u00e7ois M, Fenech MF, Leifert WR. Persistent \u03b3H2AX: a promising molecular marker of DNA damage and aging. Mutat Res - Rev Mutat Res. 2015;766:1\u201319.","journal-title":"Mutat Res - Rev Mutat Res"},{"issue":"SUPPL. 2","key":"1418_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(SUPPL. 2):214\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1418_CR18","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","volume":"46","author":"A Fabregat","year":"2018","unstructured":"Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 2018;46(D1):D649\u201355.","journal-title":"Nucleic Acids Res"},{"issue":"33","key":"1418_CR19","doi-asserted-by":"publisher","first-page":"34494","DOI":"10.18632\/oncotarget.5417","volume":"6","author":"I Kurth","year":"2015","unstructured":"Kurth I, Hein L, M\u00e4bert K, Peitzsch C, Koi L, Cojoc M, et al. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma. Oncotarget. 2015;6(33):34494\u2013509.","journal-title":"Oncotarget."},{"issue":"1","key":"1418_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.radonc.2011.05.067","volume":"101","author":"S Skvortsov","year":"2011","unstructured":"Skvortsov S, Jimenez CR, Knol JC, Eichberger P, Schiestl B, Debbage P, et al. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets. Radiother Oncol. 2011;101(1):177\u201382.","journal-title":"Radiother Oncol"},{"issue":"11","key":"1418_CR21","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1038\/bjc.2014.221","volume":"110","author":"S Skvortsov","year":"2014","unstructured":"Skvortsov S, Dud\u00e1s J, Eichberger P, Witsch-Baumgartner M, Loeffler-Ragg J, Pritz C, et al. Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). Br J Cancer. 2014;110(11):2677\u201387.","journal-title":"Br J Cancer"},{"key":"1418_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1756-9966-28-68","volume":"28","author":"L Xie","year":"2009","unstructured":"Xie L, Song X, Yu J, Wei L, Song B, Wang X, et al. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. J Exp Clin Cancer Res. 2009;28:68.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1418_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12094-012-0898-8","volume":"15","author":"LI De Llobet","year":"2013","unstructured":"De Llobet LI, Baro M, Figueras A, Modolell I, Da Silva MV, Mu\u00f1oz P, et al. Development and characterization of an isogenic cell line with a radioresistant phenotype. Clin Transl Oncol. 2013;15(3):189\u201397.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"1418_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijrobp.2010.03.002","volume":"78","author":"TY Lin","year":"2010","unstructured":"Lin TY, Chang JTC, Wang HM, Chan SH, Chiu CC, Lin CY, et al. Proteomics of the radioresistant phenotype in head-and-neck cancer: GP96 as a novel prediction marker and sensitizing target for radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(1):246\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"October","key":"1418_CR25","doi-asserted-by":"publisher","first-page":"34796","DOI":"10.1038\/srep34796","volume":"6","author":"N McDermott","year":"2016","unstructured":"McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S, et al. Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep. 2016;6(October):34796.","journal-title":"Sci Rep"},{"issue":"21","key":"1418_CR26","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1002\/pmic.200800113","volume":"8","author":"I Skvortsova","year":"2008","unstructured":"Skvortsova I, Skvortsov S, Stasyk T, Raju U, Popper B-A, Schiestl B, et al. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics. 2008;8(21):4521\u201333.","journal-title":"Proteomics."},{"issue":"3","key":"1418_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.ijrobp.2009.12.076","volume":"77","author":"YS Lee","year":"2010","unstructured":"Lee YS, Oh JH, Yoon S, Kwon MS, Song CW, Kim KH, et al. Differential gene expression profiles of Radioresistant non-small-cell lung Cancer cell lines established by fractionated irradiation: tumor protein p53-inducible protein 3 confers sensitivity to ionizing radiation. Int J Radiat Oncol Biol Phys. 2010;77(3):858\u201366.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1418_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0895-3988(08)60052-5","volume":"21","author":"QC Wei","year":"2008","unstructured":"Wei QC, Shen L, Zheng S, Zhu YL. Isolation and characterization of radiation-resistant lung cancer D6-R cell line. Biomed Environ Sci. 2008;21(4):339\u201344.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"1418_CR29","first-page":"705","volume":"28","author":"K Ogawa","year":"2006","unstructured":"Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, et al. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol. 2006;28(3):705\u201313.","journal-title":"Int J Oncol"},{"issue":"1","key":"1418_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<164::AID-IJC25>3.0.CO;2-F","volume":"73","author":"RM Harvie","year":"1997","unstructured":"Harvie RM, Davey MW, Davey RA. Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated ??-radiation. Int J Cancer. 1997;73(1):164\u20137.","journal-title":"Int J Cancer"},{"issue":"1","key":"1418_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-019-1268-2","volume":"14","author":"M Gray","year":"2019","unstructured":"Gray M, Turnbull AK, Ward C, Meehan J, Mart\u00ednez-P\u00e9rez C, Bonello M, et al. Development and characterisation of acquired radioresistant breast cancer cell lines. Radiat Oncol. 2019;14(1):1\u201319.","journal-title":"Radiat Oncol"},{"issue":"4","key":"1418_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1349-7006.2009.01082.x","volume":"100","author":"Y Kuwahara","year":"2009","unstructured":"Kuwahara Y, Li L, Baba T, Nakagawa H, Shimura T, Yamamoto Y, et al. Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays. Cancer Sci. 2009;100(4):747\u201352.","journal-title":"Cancer Sci"},{"issue":"6","key":"1418_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1667\/0033-7587(2001)156[0739:TGACOA]2.0.CO;2","volume":"750","author":"AG Pearce","year":"2001","unstructured":"Pearce AG, Segura TM, Rintala AC, Rintala-maki ND, Lee H. The generation and characterization of a radiation-resistant model system to study Radioresistance in human breast Cancer cells. Radiat Res. 2001;750(6):739\u201350.","journal-title":"Radiat Res"},{"issue":"2","key":"1418_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijom.2012.10.022","volume":"42","author":"SY Lee","year":"2013","unstructured":"Lee SY, Park HR, Cho NH, Choi YP, Rha SY, Park SW, et al. Identifying genes related to radiation resistance in oral squamous cell carcinoma cell lines. Int J Oral Maxillofac Surg. 2013;42(2):169\u201376.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"1418_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S1368-8375(97)00048-1","volume":"34","author":"T Yanagisawa","year":"1998","unstructured":"Yanagisawa T, Urade M, Takahashi Y, Kishimoto H, Sakurai K. Isolation and characterisation of radioresistant human KB carcinoma cells in vitro. Oral Oncol. 1998;34(1):30\u20138.","journal-title":"Oral Oncol"},{"issue":"3","key":"1418_CR36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0360-3016(02)03037-7","volume":"54","author":"S Henness","year":"2002","unstructured":"Henness S, Davey MW, Harvie RM, Davey RA. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression. Int J Radiat Oncol Biol Phys. 2002;54(3):895\u2013902.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1418_CR37","doi-asserted-by":"crossref","unstructured":"Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y, et al. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. 2004:91;1543\u201350.","DOI":"10.1038\/sj.bjc.6602187"},{"key":"1418_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27043","volume":"6","author":"M Borr\u00e0s-Fresneda","year":"2016","unstructured":"Borr\u00e0s-Fresneda M, Barquinero JF, Gomolka M, Hornhardt S, R\u00f6ssler U, Armengol G, et al. Differences in DNA repair capacity, cell death and transcriptional response after irradiation between a radiosensitive and a Radioresistant cell line. Sci Rep. 2016;6:1\u201311.","journal-title":"Sci Rep"},{"issue":"6","key":"1418_CR39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1099\/0022-1317-80-6-1513","volume":"80","author":"M Thomas","year":"1999","unstructured":"Thomas M, Banks L. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J Gen Virol. 1999;80(6):1513\u20137.","journal-title":"J Gen Virol"},{"issue":"11","key":"1418_CR40","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/sj.cdd.4401886","volume":"13","author":"G TO","year":"2006","unstructured":"TO G, Filippova M, Duerksen-Hughes PJ. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell Death Differ. 2006;13(11):1915\u201326.","journal-title":"Cell Death Differ"},{"issue":"9","key":"1418_CR41","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1073\/pnas.0830918100","volume":"100","author":"K Rothkamm","year":"2003","unstructured":"Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci. 2003;100(9):5057\u201362.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"1418_CR42","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/carcin\/bgv126","volume":"36","author":"R Marullo","year":"2015","unstructured":"Marullo R, Werner E, Zhang H, Chen GZ, Shin DM, Doetsch PW. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis. 2015;36(11):1397\u2013406.","journal-title":"Carcinogenesis."},{"issue":"12","key":"1418_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3109\/09553002.2015.1101501","volume":"91","author":"M Borr\u00e0s","year":"2015","unstructured":"Borr\u00e0s M, Armengol G, De Cabo M, Barquinero JF, Barrios L. Comparison of methods to quantify histone H2AX phosphorylation and its usefulness for prediction of radiosensitivity. Int J Radiat Biol. 2015;91(12):915\u201324.","journal-title":"Int J Radiat Biol"},{"issue":"6a","key":"1418_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1667\/RR2295.1","volume":"174","author":"N Lynam-Lennon","year":"2010","unstructured":"Lynam-Lennon N, Reynolds JV, Pidgeon GP, Lysaght J, Marignol L, Maher SG. Alterations in DNA repair efficiency are involved in the Radioresistance of esophageal adenocarcinoma. Radiat Res. 2010;174(6a):703\u201311.","journal-title":"Radiat Res"},{"issue":"13","key":"1418_CR45","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","volume":"21","author":"MA Morgan","year":"2015","unstructured":"Morgan MA, Lawrence TS. Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways. Clin Cancer Res. 2015;21(13):2898\u2013904.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1418_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijrobp.2003.09.028","volume":"58","author":"PL Olive","year":"2004","unstructured":"Olive PL, Ban\u00e1th JP. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys. 2004;58(2):331\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1418_CR47","doi-asserted-by":"crossref","unstructured":"Vargas-Rond\u00f3n N, Villegas VE, Rond\u00f3n-Lagos M. The Role of Chromosomal Instability in Cancer and Therapeutic Responses. Cancers (Basel). 2017;10(1):1\u201321.","DOI":"10.3390\/cancers10010004"},{"key":"1418_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fonc.2013.00113","volume":"3","author":"E Mladenov","year":"2013","unstructured":"Mladenov E, Magin S, Soni A, Iliakis G. DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy. Front Oncol. 2013;3:113.","journal-title":"Front Oncol"},{"issue":"1","key":"1418_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1667\/RR3401","volume":"164","author":"W-F Guo","year":"2005","unstructured":"Guo W-F, Lin R-X, Huang J, Zhou Z, Yang J, Guo G, et al. Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiat Res. 2005;164(1):27\u201335.","journal-title":"Radiat Res"},{"issue":"3","key":"1418_CR50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrc.2017.116","volume":"18","author":"G Nalepa","year":"2018","unstructured":"Nalepa G, Clapp DW. Fanconi anaemia and cancer: an intricate relationship. Nat Rev Cancer. 2018;18(3):168\u201385.","journal-title":"Nat Rev Cancer"},{"key":"1418_CR51","unstructured":"Spriggs CC, Laimins LA. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication. MBio. 2017;8(1):1\u201319."},{"issue":"5","key":"1418_CR52","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.biocel.2008.06.018","volume":"41","author":"A Rosemary Siafakas","year":"2009","unstructured":"Rosemary Siafakas A, Richardson DR. Growth arrest and DNA damage-45 alpha (GADD45\u03b1). Int J Biochem Cell Biol. 2009;41(5):986\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7128","key":"1418_CR53","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nature05515","volume":"445","author":"G Barreto","year":"2007","unstructured":"Barreto G, Sch\u00e4fer A, Swaminathan SK, D\u00f6derlein G, Maltry N, Stach D, et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature. 2007;445(7128):671\u20135.","journal-title":"Nature."},{"key":"1418_CR54","doi-asserted-by":"crossref","unstructured":"Wang BX, Yin BL, He B, Chen C, Zhao M, Zhang WX, et al. Overexpression of DNA damage-induced 45 a gene contributes to esophageal squamous cell cancer by promoter hypomethylation. J Exp Clin Cancer Res. 2012;31(11):1\u201313.","DOI":"10.1186\/1756-9966-31-11"},{"issue":"2","key":"1418_CR55","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/aps.2010.208","volume":"32","author":"X Zhang","year":"2011","unstructured":"Zhang X, Wei F, Zhou C, Sun S, Qu X, Wang C, et al. Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line. Acta Pharmacol Sin. 2011;32(2):253\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1418_CR56","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1038\/s41598-018-22484-6","volume":"8","author":"J Liu","year":"2018","unstructured":"Liu J, Jiang G, Mao P, Zhang J, Zhang L, Liu L, et al. Down-regulation of GADD45A enhances chemosensitivity in melanoma. Sci Rep. 2018;8(1):4111.","journal-title":"Sci Rep"},{"issue":"2","key":"1418_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2478\/s11658-012-0012-9","volume":"17","author":"SJ Yan","year":"2012","unstructured":"Yan SJ, Lee YF, Ting HJ, Liu NC, Liu S, Lin SJ, et al. Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation. Cell Mol Biol Lett. 2012;17(2):309\u201322.","journal-title":"Cell Mol Biol Lett"},{"key":"1418_CR58","doi-asserted-by":"crossref","unstructured":"Weyemi U, Redon CE, Choudhuri R, Aziz T, Maeda D, Boufraqech M, et al. The histone variant H2A.X is a regulator of the epithelial\u2013mesenchymal transition. Nat Commun. 2016;7:1\u201312.","DOI":"10.1038\/ncomms10711"},{"issue":"5","key":"1418_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.dnarep.2010.01.016","volume":"9","author":"CE Tambini","year":"2010","unstructured":"Tambini CE, Spink KG, Ross CJ, Hill MA, Thacker J. The importance of XRCC2 in RAD51-related DNA damage repair. DNA Repair (Amst). 2010;9(5):517\u201325.","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"1418_CR60","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/ijms15022157","volume":"15","author":"Q Wang","year":"2014","unstructured":"Wang Q, Wang Y, Du L, Xu C, Sun Y, Yang B, et al. Shrna-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivo. Int J Mol Sci. 2014;15(2):2157\u201371.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1418_CR61","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1016\/j.celrep.2018.11.085","volume":"25","author":"S Saxena","year":"2018","unstructured":"Saxena S, Somyajit K, Nagaraju G. XRCC2 Regulates Replication Fork Progression during dNTP Alterations. Cell Rep. 2018;25(12):3273\u20133282.e6.","journal-title":"Cell Rep"},{"issue":"12","key":"1418_CR62","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/cas.12820","volume":"106","author":"J Cheng","year":"2015","unstructured":"Cheng J, Liu W, Zeng X, Zhang B, Guo Y, Qiu M, et al. XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma. Cancer Sci. 2015;106(12):1678\u201386.","journal-title":"Cancer Sci"},{"issue":"4","key":"1418_CR63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd1691","volume":"4","author":"D Wang","year":"2005","unstructured":"Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Deliv. 2005;4(4):307\u201320.","journal-title":"Nat Rev Drug Deliv"},{"issue":"3","key":"1418_CR64","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3892\/ol.2015.3411","volume":"10","author":"C Sun","year":"2015","unstructured":"Sun C, Wang Z, Song W, Chen B, Zhang J, Dai X, et al. Alteration of DNA damage signaling pathway profile in radiation-treated glioblastoma stem-like cells. Oncol Lett. 2015;10(3):1769\u201374.","journal-title":"Oncol Lett"},{"issue":"3","key":"1418_CR65","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1124\/pr.111.005637","volume":"64","author":"D-W Shen","year":"2012","unstructured":"Shen D-W, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64(3):706\u201321.","journal-title":"Pharmacol Rev"},{"key":"1418_CR66","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2016.03.006","volume":"95","author":"CW Fong","year":"2016","unstructured":"Fong CW. Platinum anti-cancer drugs: free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect. Free Radic Biol Med. 2016;95:216\u201329.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1418_CR67","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.oraloncology.2013.03.446","volume":"49","author":"R Nagel","year":"2013","unstructured":"Nagel R, Martens-de Kemp SR, Buijze M, Jacobs G, Braakhuis BJM, Brakenhoff RH. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines. Oral Oncol. 2013;49(6):560\u20136.","journal-title":"Oral Oncol"},{"issue":"24","key":"1418_CR68","doi-asserted-by":"publisher","first-page":"35832","DOI":"10.18632\/oncotarget.9028","volume":"7","author":"C-J Busch","year":"2016","unstructured":"Busch C-J, Becker B, Kriegs M, Gatzemeier F, Kr\u00fcger K, M\u00f6ckelmann N, et al. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines. Oncotarget. 2016;7(24):35832\u201342.","journal-title":"Oncotarget."},{"issue":"24","key":"1418_CR69","doi-asserted-by":"publisher","first-page":"524","DOI":"10.21037\/atm.2016.12.45","volume":"4","author":"S Pardo-Reoyo","year":"2016","unstructured":"Pardo-Reoyo S, Roig-Lopez JL, Yang ES. Potential biomarkers for radiosensitivity in head and neck cancers. Ann Transl Med. 2016;4(24):524.","journal-title":"Ann Transl Med"},{"issue":"4","key":"1418_CR70","first-page":"313","volume":"19","author":"M Wierzbicka","year":"2015","unstructured":"Wierzbicka M, Szyfter K, Milecki P, Sk\u0142adowski K, Ramlau R. The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies. Contemp Oncol (Poznan). 2015;19(4):313\u201322.","journal-title":"Contemp Oncol (Poznan)"},{"issue":"6","key":"1418_CR71","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.oraloncology.2013.09.015","volume":"50","author":"RJ Kimple","year":"2014","unstructured":"Kimple RJ, Harari PM. Is radiation dose reduction the right answer for HPV-positive head and neck cancer? Oral Oncol. 2014;50(6):560\u20134.","journal-title":"Oral Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1418-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1418-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1418-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:13:55Z","timestamp":1606349635000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1418-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1418"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1418-6","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"14 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}